We help pharmaceutical, biotech, and medtech companies transform their medical affairs function into a strategic pillar that drives scientific engagement, evidence generation, and commercial impact.

NDB Holding Group supports clients in aligning medical affairs with broader organizational priorities, navigating regulatory and compliance requirements, and leveraging scientific expertise to create value for patients, providers, and stakeholders. This includes establishing governance frameworks, building capabilities, and implementing data-driven strategies to maximize impact.

Our Medical Affairs Practice works with global and regional organizations across pharmaceuticals, biologics, and medical devices. With a global presence, we help clients benchmark performance, optimize organizational structure, and identify opportunities to improve scientific engagement, evidence generation, and stakeholder collaboration.

We advise clients on strategy, operations, organizational design, and digital enablement. Many of our consultants have backgrounds in clinical research, regulatory sciences, and healthcare strategy, giving them deep insight into medical communications, medical science liaison (MSL) programs, and evidence-based stakeholder engagement.

Our areas of expertise include:

• Medical affairs strategy: Defining the role of medical affairs as a strategic pillar alongside R&D and commercial, and developing long-term roadmaps for organizational impact.

• Organizational design and capability building: Structuring teams, defining roles, and creating learning programs to enhance scientific and commercial effectiveness.

• Scientific communication and stakeholder engagement: Developing publication strategies, medical education programs, and MSL deployment to strengthen scientific credibility.

• Evidence generation and clinical insights: Supporting post-market studies, real-world evidence generation, and clinical advisory boards to inform strategy and decision-making.

• Digital enablement: Implementing advanced analytics, digital collaboration platforms, and medical information systems to improve efficiency and impact.

Recent example of our work:
We helped a global pharmaceutical company transform its medical affairs organization by redesigning the MSL network, implementing a digital knowledge platform, and establishing integrated evidence-generation initiatives. These efforts increased stakeholder engagement by 30%, accelerated evidence delivery timelines, and enhanced alignment with commercial and R&D priorities.